埃弗B受体活性抑制结直肠癌的进展
Eduard Batlle1, Julinor Bacani, Harry Begthel
1Hubrecht Laboratory, Center for Biomedical Genetics, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Nature
|June 24, 2005
概括
失去EphB受体表达是结直肠癌进展的关键一步,加速瘤生长和恶性瘤. 这一发现突出了EphB的发现.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞信号传递 细胞信号传递
背景情况:
- 大肠直肠癌 (CRC) 通常源于Wnt通路的突变,导致β-catenin稳定和TCF-4介导的转录.
- 由TCF-4调节的EphB受体,通过Ephrin-B相互作用对肠上皮质结构至关重要.
研究的目的:
- 研究EphB受体表达在结直肠癌进展中的作用.
- 为了确定EphB损失和癌症恶性之间的相关性.
主要方法:
- 在不同阶段的人类结直肠瘤中分析EphB表达.
- 对EphB表达水平和瘤等级之间的相关性分析.
- 实验操作的EphB活动 Apc ((Min/+) 结肠癌的小鼠模型.
主要成果:
- 大多数人类结肠直肠癌在腺瘤转移时表现出EphB表达的丧失,尽管持续Wnt通路激活.
- 减少EphB表达与瘤恶性增加有很强的相关性.
- 在小鼠中,EphB活性下降加速了结肠和直肠瘤发生,导致了侵略性的腺癌.
结论:
- 失去EphB受体表达是结直肠癌进展的一个关键事件.
- 在抑制瘤发育和维持结肠上皮质结构方面,EphB信号传递起着至关重要的作用.
- 准EphB信号可能为结直肠癌提供治疗策略.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...